← back to search

Rosaline C. M. Quinlivan

University of Ferrara · IT
🔎 Find collaborators in Molecular Biology · Rheumatology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Rheumatology
Research interest
Research focused on Rhabdomyolysis and Spinal muscular atrophy, with related work in Myoglobinuria, Placebo, Clinical endpoint. Notable publications include 'Ataluren treatment of patients with nonsense mutation dystrophinopathy', 'Mutations in GDP-Mannose Pyrophosphorylase B Cause Congenital and Limb-Girdle Muscular Dystrophies Associated with Hypoglycosylation of α-Dystroglycan', and 'Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled...'.
h-index
citations
2,176
works
19
NIH funding
primary concept
email

Recent publications

Transforming molecular neuropathology for adult brain tumor patients in the UK: Insights on implementation, adoption, and patient access (2021-2024)
Neuro-Oncology Practice 2025cited by 2position: middledoi
A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry
Nature Communications 2024cited by 28position: middledoi
263rd ENMC International Workshop: Focus on female carriers of dystrophinopathy: refining recommendations for prevention, diagnosis, surveillance, and treatment. Hoofddorp, The Netherlands, 13-15 May 2022
Neuromuscular Disorders 2023cited by 29position: middledoi
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial
The Lancet Neurology 2022cited by 103position: middledoi
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
The Lancet Neurology 2021cited by 211position: middledoi
Making sense of missense variants in TTN-related congenital myopathies
Acta Neuropathologica 2021cited by 66position: middledoi
The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations
Journal of Neurology 2019cited by 38position: middledoi
Atypical periodic paralysis and myalgia
Neurology 2018cited by 53position: middledoi
Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy
Cochrane Database of Systematic Reviews 2018cited by 47position: lastdoi
Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy?
BMJ Open Sport & Exercise Medicine 2016cited by 115position: middledoi
CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies
Neuromuscular Disorders 2016cited by 48position: lastdoi
Rhabdomyolysis: a genetic perspective
Orphanet Journal of Rare Diseases 2015cited by 149position: lastdoi
Ataluren treatment of patients with nonsense mutation dystrophinopathy
Muscle & Nerve 2014cited by 426position: middledoi
Truncating and Missense Mutations in IGHMBP2 Cause Charcot-Marie Tooth Disease Type 2
The American Journal of Human Genetics 2014cited by 110position: middledoi
Mutations in GDP-Mannose Pyrophosphorylase B Cause Congenital and Limb-Girdle Muscular Dystrophies Associated with Hypoglycosylation of α-Dystroglycan
The American Journal of Human Genetics 2013cited by 239position: middledoi
Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis
Neuromuscular Disorders 2013cited by 198position: middledoi
Hereditary myopathy with early respiratory failure: occurrence in various populations
Journal of Neurology Neurosurgery & Psychiatry 2013cited by 85position: middledoi
Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies
Human Mutation 2012cited by 167position: middledoi
Myopathic causes of exercise intolerance with rhabdomyolysis
Developmental Medicine & Child Neurology 2012cited by 62position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Heinz Jungbluth · King's College London5 papers (2012–2019)R. Scalco · University College London4 papers (2015–2019)Nicol C. Voermans · Radboud University Nijmegen3 papers (2016–2023)Janice L. Holton · University College London3 papers (2015–2019) · 2 papers (2018–2023)Susan Treves · University of Ferrara2 papers (2016–2018) · 2 papers (2016–2019)Henry Houlden · University College London Hospitals NHS Foundation Trust2 papers (2015–2018)Erik‐Jan Kamsteeg · Radboud University Nijmegen1 papers (2019–2019) · 1 papers (2023–2023)Emma Matthews · University of London1 papers (2018–2018)Nicola Peat · St Thomas' Hospital1 papers (2025–2025) · 1 papers (2023–2023)Jacqueline Palace · National Health Service1 papers (2018–2018)Joanne Lewis · European Molecular Biology Laboratory1 papers (2025–2025)Karen Suetterlin · The Ohio State University Wexner Medical Center1 papers (2018–2018)Dipa Raja Rayan · University of Ferrara1 papers (2018–2018) · 1 papers (2025–2025) · 1 papers (2025–2025)Richa Sud · The Ohio State University Wexner Medical Center1 papers (2018–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Rheumatology →